Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Obstetrics & Gynaecology

Clinical Pharmacology

Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: A phase 3, randomized, double-blind, placebo-controlled, multicenter trial

Menopause | Jun 07, 2019 Clinical Pharmacology

Menopausal hormone therapy trends before vs after 2002: Impact of the Women's Health Initiative Study Results

Menopause | Jun 07, 2019 Clinical Pharmacology

Tumor-stroma proportion as a predictive biomarker of resistance to platinum-based chemotherapy in patients with ovarian cancer

JAMA Oncology | Jun 07, 2019 Clinical Pharmacology

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial

European Journal of Cancer | Jun 06, 2019 Clinical Pharmacology

Clinical characteristics and outcomes in elderly women with BRCA1 and BRCA2 mutations

Gynecologic Oncology | Jun 06, 2019 Clinical Pharmacology

Vaginal estrogen use and chronic disease risk in the Nurses’ Health Study

Menopause | Jun 06, 2019 Clinical Pharmacology

Randomized trial of intravenous vs intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study

Journal of Clinical Oncology | Jun 04, 2019 Clinical Pharmacology

Clinical outcomes after isolated pelvic failure in cervical cancer patients treated with definitive radiation

Gynecologic Oncology | Jun 02, 2019 Clinical Pharmacology

Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial – ANZGOG 0903

Gynecologic Oncology | May 27, 2019 Clinical Pharmacology

The association between metformin therapy and risk of gynecological cancer in patients: Two meta-analyses

European Journal of Obstetrics & Gynecology and Reproductive Biology | May 26, 2019 Clinical Pharmacology

« Prev 1 … 60 61 62 63 64 … 106 Next »

Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: A phase 3, randomized, double-blind, placebo-controlled, multicenter trial

Menopausal hormone therapy trends before vs after 2002: Impact of the Women's Health Initiative Study Results

Tumor-stroma proportion as a predictive biomarker of resistance to platinum-based chemotherapy in patients with ovarian cancer

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial

Clinical characteristics and outcomes in elderly women with BRCA1 and BRCA2 mutations

Vaginal estrogen use and chronic disease risk in the Nurses’ Health Study

Randomized trial of intravenous vs intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study

Clinical outcomes after isolated pelvic failure in cervical cancer patients treated with definitive radiation

Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial – ANZGOG 0903

The association between metformin therapy and risk of gynecological cancer in patients: Two meta-analyses

Dental Implants in Paediatric Dentistry

Breathwork & Its Impact on the Nervous System: Applications for Stress Relief

Alzheimer's may not actually be a brain disease, says expert

Certain Cancer Rates Tripled in Millennials vs Boomers—Why is a ‘Healthier’ and Younger Generation at Higher Risk?

Anti-obesity medication boosts weight loss when behavioural therapy falls short

Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: A phase 3, randomized, double-blind, placebo-controlled, multicenter trial

Menopausal hormone therapy trends before vs after 2002: Impact of the Women's Health Initiative Study Results

Tumor-stroma proportion as a predictive biomarker of resistance to platinum-based chemotherapy in patients with ovarian cancer

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial

Clinical characteristics and outcomes in elderly women with BRCA1 and BRCA2 mutations

Vaginal estrogen use and chronic disease risk in the Nurses’ Health Study

Randomized trial of intravenous vs intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study

Clinical outcomes after isolated pelvic failure in cervical cancer patients treated with definitive radiation

Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial – ANZGOG 0903

The association between metformin therapy and risk of gynecological cancer in patients: Two meta-analyses

Dental Implants in Paediatric Dentistry

Breathwork & Its Impact on the Nervous System: Applications for Stress Relief

Alzheimer's may not actually be a brain disease, says expert

Certain Cancer Rates Tripled in Millennials vs Boomers—Why is a ‘Healthier’ and Younger Generation at Higher Risk?

Anti-obesity medication boosts weight loss when behavioural therapy falls short

Select Specialty

Select Topic